Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cavitation Technologies (CVAT) Cash & Equivalents (2016 - 2025)

Cavitation Technologies' Cash & Equivalents history spans 16 years, with the latest figure at $31000.0 for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 95.45% year-over-year to $31000.0; the TTM value through Dec 2025 reached $31000.0, down 95.45%, while the annual FY2025 figure was $249000.0, 39.11% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $31000.0 at Cavitation Technologies, up from $30000.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $1.9 million in Q3 2021 and bottomed at $7000.0 in Q4 2023.
  • The 5-year median for Cash & Equivalents is $326500.0 (2022), against an average of $471937.5.
  • The largest annual shift saw Cash & Equivalents plummeted 97.96% in 2023 before it skyrocketed 9628.57% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $1.1 million in 2021, then tumbled by 68.82% to $343000.0 in 2022, then tumbled by 97.96% to $7000.0 in 2023, then surged by 9628.57% to $681000.0 in 2024, then tumbled by 95.45% to $31000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVAT's Cash & Equivalents are $31000.0 (Q4 2025), $30000.0 (Q3 2025), and $249000.0 (Q2 2025).